CURRICULUM VITAE. Suzane Silbert
|
|
- Alexis Goodwin
- 5 years ago
- Views:
Transcription
1 CURRICULUM VITAE Suzane Silbert, PhD 1. PERSONAL DATA Name: Suzane Silbert Sex: Female Date of Birth: October 27, 1968 Place of Birth: Porto Alegre, Brazil Marital Status: Married addresses: Present Address: Esoteric Testing Laboratory Clinical Lab/Pathology Department Tampa General Hospital One Tampa General Circle Tampa, Florida EDUCATION Biological Sciences: Pontifícia Universidade Católica do Rio Grande do Sul. Porto Alegre, RS, Brazil. From: 1986 to Master Degree: Thesis: Evaluation of the Antimicrobial Susceptibility and Molecular Typing of Pseudomonas aeruginosa isolated from CF patients. [Avaliação do Perfil de Sensibilidade a Antimicrobianos e Tipagem Molecular de Pseudomonas aeruginosa isoladas de pacientes portadores de Fibrose Cística]. Infectious and Parasitologic Diseases Program. Federal University of São Paulo. São Paulo, SP, Brazil. From: 1997 to Ph.D Degree: Thesis: Molecular Typing of Non-Fermentative Gram-Negative Bacilli: Applicability of Different Techniques. [Tipagem Molecular de Bacilos Gram-Negativos Não-Fermentadores: Comparação e Aplicabilidade de Diferentes Técnicas]. Infectious and Parasitologic Diseases Program. Federal University of São Paulo. São Paulo, SP, Brazil. From: 2000 to PROFESSIONAL TITLES AND LICENSES: Certified as a Specialist in Microbiology and Molecular Biology: Conselho Regional de Biologia 1 Região (Brazilian Biology Board), Certified as a Medical Technologist: Board of Directors, American Medical Technologists, AMT, ID Number: Certified as a Clinical Laboratory Technologist in Microbiology: Florida Board of Clinical Laboratory Personnel Licensure, License Number: TN
2 4.1. POSITIONS AND EMPLOYMENT Microbiologist of the Clinical Microbiology Laboratory Pathology Department - Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil. September 1991 to June 1997 Microbiologist of the Sexual Transmitted Diseases Laboratory Pregnant Women HIV Clinic - Federal University of São Paulo EPM São Paulo, SP, Brazil. October 1997 to March 1999 Supervisor of the Special Clinical Microbiology Laboratory Infectious Diseases Division - Federal University of Sao Paulo EPM São Paulo, SP, Brazil. June 2000 to March 2004 Lab Technical Coordinator Department of Clinical Pathology Albert Einstein Hospital (Certified by Joint Commission International) São Paulo, SP, Brazil. March 2004 to June 2007 Molecular Typing Lab Section Coordinator Infectious Diseases Division - Federal University of Sao Paulo EPM São Paulo, SP, Brazil. June 2000 to August 2007 Clinical Microbiologist Investigator Infectious Disease Section Bay Pines VA Healthcare System VHCS Bay Pines, FL. USA. November 2007 to May 2009 Clinical Scientist Esoteric Testing Laboratory - Clinical Lab/Pathology Department Tampa General Hospital. June 2009 to present 4.2. PROFESSIONAL TRAINING Genetic Department Federal University of Rio Grande do Sul Porto Alegre, RS, Brazil. August 1986 to July 1987 Clinical Microbiology Laboratory Clinical Pathology Department - Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil. April 1988 to May 1991 Micology Laboratory Dermatology Service - Santa Casa de Misericórdia do Rio de Janeiro Rio de Janeiro, RJ, Brazil. June to August 1991 Microbiology Laboratories Royal Brompton Hospital and Central Public Health Laboratory London, UK. October 1992 Laboratory of Hospital Infection Central Public Health Laboratory London, UK. March
3 Molecular Epidemiology and Fungus Testing Lab Pathology Department - University of Iowa Hospitals and Clinics Iowa City, IA, USA. April 1999 to May PEER-REVIEWED PUBLICATIONS 5.1. Silbert, S, Rosa, D, Matte, U, Goldim, JR, Barcellos, S, Procianoy, R. Staphylococcus sp. coagulase negative from blood cultures of newborn patients: infection versus contamination. Jornal de Pediatria. May, E. Sprinz, R.Mallman, S.Barcellos, S.Silbert, G.Schestatsky and Bem David. Aids-related cryptosporidial diarrhoea: an open study with roxithromycin. Journal of Antimicrobial Chemotherapy. 41, Suppl.B, Roland, RK; Mendes, RE; Silbert, S; Bolsoni, AP. Sader, HS. In vitro Antimicrobial Activity of Piperacillin/Tazobactam in Comparison With Other Broad Spectrum ß-Lactams. The Brazilian Journal of Infectious Diseases. 4 (5): Silbert, S.; Barth AL; Sader, HS. Heterogeneity of Pseudomonas aeruginosa in Brazilian Cystic Fibrosis Patients. Journal of Clinical Microbiology. 39 (11): Cereda, R.F.; Gales, AC; Silbert, S; Jones, RN; Sader, HS. Molecular Typing and Antimicrobial Susceptibility of Vancomycin-Resistant Enterococcus faecium (VRE) in Brazil. Infection Control Hospital Epidemiology. 23(1): Sejas, LM; Silbert, S; Reis, AO; Sader, HS. Evaluation of the quality of the antimicrobial agents disks used in disk-diffusion tests commercially available in Brazil. Jornal Brasileiro de Patologia. 39 (1): 27-35, Gales, AC; Menezes, LC; Silbert, S; Sader, HS. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo- -lactamase. Journal of Antimicrobial Chemotherapy. 52: , Silbert, S; Boyken, L; Hollis, RJ; Pfaller, MA. Improving Typeability of Multiple Bacterial Species Using Pulsed-Field Gel Electrophoresis and Thiourea. Diagnostic Microbiology and Infectious Diseases. 47 (4): , Castanheira, M; Jones, RN; Silbert, S; Brandileone, MCC; Sader, HS. Typing and Molecular Characterization of Streptococcus pneumoniae with Reduced Susceptibility to Cefotaxime Isolated in Latin America. Microbial Drug Resistance Mechanisms Epidemiology and Disease. 9 (4): , Tosin, I; Silbert, S; Sader, HS. The use of Molecular Typing to Evaluate the Dissemination of Antimicrobial Resistance among Gram-negative Rods in Brazilian Hospitals. The Brazilian Journal of Infectious Diseases. 7(6): , Cordeiro, JCR; Silbert, S; Reis, AO; Sader, HS. Inter-Hospital Dissemination of Glycopeptide Resistant Enterococcus faecalis in Brazil. Clinical Microbiology and Infection. 10(3): , Silbert, S.; Pfaller MA; Hollis RJ; Barth AL; Sader HS. Evaluation of Three Molecular Typing Techniques for Nonfermentative Gram-Negative Bacilli. Infection Control and Hospital Epidemiology. 25(10): , Barbosa D; Lima L; Silbert, S.; Sader HS; Cendoroglo M; Draibe S; Camargo L; Vianna L; A. Belasco; Sesso R. Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis. Am Journal of Kidney Diseases. 44(2): ,
4 5.14. Tognin MC; Andrade SS; Silbert, S.; Gales AC; Jones RN; Sader HS. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program. International Journal of Infectious Diseases.8: , Sader HS; Reis AO; Silbert, S; Gales AC. IMPs, VIMs and SPMs: the diversity of metallo-betalactamases in a Brazilian hospital. Clinical Microbiology and Infection. 11: 73-76, Ribeiro J; Mendes RE; Domingos R; França E; Silbert, S; Jones RN; Sader HS. Microbiological and Epidemiological Characterization of Imipenem-Resistant Pseudomonas aeruginosa Strains from a Brazilian Tertiary Hospital: Report from the SENTRY Antimicrobial Surveillance Program. Journal of Chemotherapy.18: , Freitas, MC; Pacheco-Silva, A; Barbosa D; Silbert, S; Sader HS; Sesso R; Camargo, LFA. Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients. BMC Infectious Diseases (Online). 6: 133, Tognin MC; Gales AC; Penteado A; Silbert, S; Sader HS. Dissemination of IMP-1 Metallo-Beta- Lactamase-Producing Acinetobacter spp. in a Brazilian Teaching Hospital. Infection Control and Hospital Epidemiology. 27 (7): , Zavascki, A., Soares, F., Superti, S., Silbert, S., Silva, F. M., Barth AL. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa. International Journal of Antimicrobial Agents, 30: , R. Sitnik, H. Sette Jr., R.A.F. Santana, L.C. Menezes, C.H.N. Graça, G.T.F. Dastoli, S. Silbert, J.R.R. Pinho. Hepatitis B virus genotype E detected in Brazil in an African patient who is a frequent traveler. Brazilian Journal of Medical and Biological Research, 40 (12): , Almeida, M. T. G., Rubio, F. G., Garcia, D. O., Pavarino-Bertelli, E. C., Rossit, A. R. B., Bando, S. Y., Silbert, S., Goloni-Bertollo, E. M., Soares, M. M. C. N., Martinez, M. B. Genetic relatedness among clinical strains of Stenotrophomonas maltophilia in tertiary care hospital settings in Sao Paulo State, Brazil. Brazilian Journal of Microbiology,38: , d'azevedo, P. A., Furtado, G., Medeiros EAS, Santiago, K. A., Silbert, S, Pignatari ACC. Molecular characterization of vancomycin-resistant Enterococci strain eight years apart from its first isolation in São Paulo, Brazil. Journal of the São Paulo Institute of Tropical Medicine [Revista do Instituto de Medicina Tropical de São Paulo], 50: , Silva, F.M., Carmo, M.S., Silbert, S., Gales, A.C. SPM-1-Producing Pseudomonas aeruginosa: Analysis of the Ancestor Relationship Using Multilocus Sequence Typing, Pulsed-Field Gel Electrophoresis, and Automated Ribotyping. Microbial Drug Resistance, 17 (2): , Monteiro, J., Widen, R., Kubasek, C., Pignatari, A.C.C., Silbert, S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother, doi: /jac/dkr563. Jan, BOOK CHAPTER 6.1. Sitnik, R; Silbert, S; Pinho, JRR. Viral Resistance: Genotyping, Phenotyping and Virtual Phenotyping. [Resistência Viral: Genotipagem, Fenotipagm e Fenotipagem Virtual]. In: Roberto Focaccia. (Org.) VERONESI - Tratado de Infectologia. 3 ed. São Paulo: Atheneu, 2005, 1:
5 7. AD HOC REVIEWER 7.1. Diagnostic Microbiology and Infectious Diseases. Since: Infection Control and Hospital Epidemiology. Since: American Journal of Infection Control. Since: Brazilian Journal of Microbiology. Since: Journal of Antimicrobial Chemotherapy. Since: Journal of Medical Microbiology. Since: Journal of Virological Methods. Since: Journal of Cystic Fibrosis. Since: Molecular Biology Reports. Since: INVITED LECTURES, COURSES MINISTRATED AND CONFERENCES PRESENTATION Total: POSTER PRESENTATIONS IN SCIENTIFIC MEETINGS Total: SCIENTIFIC SOCIETY MEMBERSHIP American Society for Microbiology: Membership # Since: PARTICIPATION IN MEETINGS, SYMPOSIUMS AND COURSES Sixty-three participations in meetings, symposiums and courses, most of them about Clinical Microbiology and Molecular Biology. Updated: Dec,
Antimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil
BJID 2001; 5 (August) 171 Antimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil Helio S. Sader, Ana C. Gales and Ronald N. Jones Special Clinical Microbiology Laboratory, Division
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationA snapshot of polymyxin use around the world South America
A snapshot of polymyxin use around the world South America Alexandre P. Zavascki Infectious Diseases Service, Hospital de Clínicas de Porto Alegre Medical School, Federal University of Rio Grande do Sul
More informationDOI: /
Jornal Brasileiro de Patologia e Medicina Laboratorial ISSN: 1678-4774 Sociedade Brasileira de Patologia Clínica; Sociedade Brasileira de Patologia; Sociedade Brasileira de Citopatologia Paula, Milena
More informationNew Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs
New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs Patrick R. Murray, PhD Senior Director, WW Scientific Affairs 2017 BD. BD, the BD Logo and all other trademarks
More informationBJID 2001; 5 (February) 21
BJID 2001; 5 (February) 21 Antimicrobial Susceptibility of Quinupristin/Dalfopristin Tested Against Gram-Positive Cocci From Latin America: Results from the Global SMART (GSMART) Surveillance Study Helio
More informationC&W Three-Year Cumulative Antibiogram January 2013 December 2015
C&W Three-Year Cumulative Antibiogram January 213 December 215 Division of Microbiology, Virology & Infection Control Department of Pathology & Laboratory Medicine Contents Comments and Limitations...
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationThe Challenges of Antimicrobial Resistance in Brazil
ANTIMICROBIAL RESISTANCE George M. Eliopoulos, Section Editor INVITED ARTICLE The Challenges of Antimicrobial Resistance in Brazil Flávia Rossi Pathology Department, DLC_LIM 03, Hospital das Clínicas da
More informationAntimicrobial Resistance Strains
Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant
More informationOriginal Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):
Original Articles Analysis of blood/tracheal culture results to assess common pathogens and pattern of antibiotic resistance at medical intensive care unit, Lady Ridgeway Hospital for Children K A M S
More information2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital
2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram
More informationDEPARTMENT OF MEDICAL MICROBIOLOGY
1. Title of Subject: Tumor viruses and oncogenes DEPARTMENT OF MEDICAL MICROBIOLOGY semester: 2 nd Coordinator: Dr. György Veress Instructors: Dr. György Veress Entrance conditions: Final exam from Medical
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More informationHEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE
Universidade de São Paulo Departamento de Moléstias Infecciosas e Parasitárias HEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE Anna S. Levin 4 main lines! Epidemiology of HAS and resistance!
More information1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection
Surveillance, Outbreaks, and Reportable Diseases, Oh My! Assisted Living Facility, Nursing Home and Surveyor Infection Prevention Training February 2015 A.C. Burke, MA, CIC Health Care-Associated Infection
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationSummary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More informationRCH antibiotic susceptibility data
RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological
More informationInternational Journal of Pharma and Bio Sciences ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI ABSTRACT
Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI * PRABHAKAR C MAILAPUR, DEEPA
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationAntimicrobial activity of ceftobiprole against Gram-negative and Gram-positive pathogens: results from INVITA-A-CEFTO Brazilian study
Antimicrobial activity of ceftobiprole against Gram-negative and Gram-positive pathogens: results from INVITA-A-CEFTO Brazilian study ORIGINAL ARTICLE ABSTRACT Ceftobiprole is a broad-spectrum cephalosporin
More informationReport on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli"
Preserving the Power of Antibiotics Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli" Held on Thursday, September 30, 2004 in Boston, MA Preceding
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXVII NUMBER 6 July 2012 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine B. Dowell SM, MLS (ASCP); Sarah K. Parker, MD; James K. Todd, MD Each year the Children s Hospital Colorado
More informationDalbavancin, enterococci, Gram-positive cocci, Latin America, staphylococci, streptococci
ORIGINAL ARTICLE 10.1111/j.1469-0691.2004.01051.x Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres A. C. Gales 1, H. S. Sader 1,2
More informationMultidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?
Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Roberta B. Carey, PhD Centers for Disease Control and Prevention Division of Healthcare Quality Promotion Why worry? MDROs Clinical
More informationUCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients
Background/methods: UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients This guideline establishes evidence-based consensus standards for management
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More information2 P. aeruginosa: Resistance and Molecular Typing BJI 2002; 6 (February) macrorestriction analysis by pulsed field gel electrophoresis, have been succe
BJI 2002; 6 (February) 1 Antibiotic Resistance and Molecular Typing of Pseudomonas aeruginosa: Focus on Imipenem Ana Lúcia Peixoto de Freitas and Afonso Luis Barth Federal University of Rio Grande do Sul,
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More informationORIGINAL ARTICLE. influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.
ORIGINAL ARTICLE Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997 98 I. A. Critchley 1, C. Thornsberry
More informationDoripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities
REVIEW Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities Fiona Walsh Department of Clinical Microbiology, Trinity College Dublin, Dublin, Ireland
More information2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital
2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....
More informationMulti-Drug Resistant Organisms (MDRO)
Multi-Drug Resistant Organisms (MDRO) 2016 What are MDROs? Multi-drug resistant organisms, or MDROs, are bacteria resistant to current antibiotic therapy and therefore difficult to treat. MDROs can cause
More informationMicrobiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:
Microbiology Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention June 2017 MeshHp (VS) Medical Care Center Dr. Eberhard & Partner Dortmund (ÜBAG) www.labmed.de MVZ Dr. Eberhard &
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationRETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR
Original article RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR R.Sujatha 1,Nidhi Pal 2, Deepak S 3 1. Professor & Head, Department
More informationRESISTANT PATHOGENS. John E. Mazuski, MD, PhD Professor of Surgery
RESISTANT PATHOGENS John E. Mazuski, MD, PhD Professor of Surgery Disclosures Contracted Research: AstraZeneca, Bayer, Merck. Advisory Boards/Consultant: Allergan (Actavis, Forest Laboratories), AstraZeneca,
More informationPublic Health Response to Emerging Resistance
National Center for Emerging and Zoonotic Infectious Diseases Public Health Response to Emerging Resistance Alex Kallen, MD, MPH, FACP Lead Antimicrobial Resistance and Emerging Pathogens Team Prevention
More informationChallenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems
Micro 301 Antimicrobial Drugs 11/7/12 Significance of antimicrobial drugs Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Definitions Antibiotic Selective
More informationBACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)
BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016) VA Palo Alto Health Care System April 14, 2017 Trisha Nakasone, PharmD, Pharmacy Service Russell Ryono, PharmD, Public Health Surveillance
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationTrends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: a 4-year study
Trends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: a 4-year study Evolução da resistência aos antimicrobianos entre isolados clínicos de enterococos
More informationAntimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013
Antimicrobial Resistance Surveillance from sentinel public s, South Africa, 213 Authors: Olga Perovic 1,2, Melony Fortuin-de Smidt 1, and Verushka Chetty 1 1 National Institute for Communicable Diseases
More information2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationMajor Article. Luciana Azevedo Callefi [1], Eduardo Alexandrino Servolo de Medeiros [1] and Guilherme Henrique Campos Furtado [1] INTRODUCTION METHODS
Revista da Sociedade Brasileira de Medicina Tropical 46(1):45-49, Jan-Feb, 2013 http://dx.doi.org/10.1590/0037-868216622013 Major Article Impact of the introduction of an automated microbiologic system
More informationAntibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units
NEW MICROBIOLOGICA, 34, 291-298, 2011 Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units Vladimíra Vojtová 1, Milan Kolář 2, Kristýna Hricová 2, Radek Uvízl 3, Jan Neiser
More informationSurveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,
Original Article Vol. 28 No. 1 Surveillance of Antimicrobial Resistance:- Chaiwarith R, et al. 3 Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at
More informationMechanism of antibiotic resistance
Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance
More informationAntimicrobial Stewardship:
Antimicrobial Stewardship: Inpatient and Outpatient Elements Angela Perhac, PharmD afperhac@carilionclinic.org Disclosure I have no relevant finances to disclose. Objectives Review the core elements of
More informationDetecting / Reporting Resistance in Nonfastidious GNR Part #2. Janet A. Hindler, MCLS MT(ASCP)
Detecting / Reporting Resistance in Nonfastidious GNR Part #2 Janet A. Hindler, MCLS MT(ASCP) Methods Described in CLSI M100-S21 for Testing non-enterobacteriaceae Organism Disk Diffusion MIC P. aeruginosa
More informationHuman health impacts of antibiotic use in animal agriculture
Human health impacts of antibiotic use in animal agriculture Beliefs, opinions, and evidence Peter Davies BVSc, PhD College of Veterinary Medicine, University of Minnesota, USA Terminology Antibiotic Compound
More information9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS
Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS 1 2 Untoward Effects of Antibiotics Antibiotic resistance Adverse drug events (ADEs) Hypersensitivity/allergy Drug side effects
More informationCAVICIDE1. Technical Bulletin
CAVICIDE1 Technical Bulletin CaviCide1 is a multi-purpose disinfectant intended for use in cleaning, decontaminating and disinfecting hard non-porous, inanimate surfaces and non-critical instruments in
More informationHospital ID: 831. Bourguiba Hospital. Tertiary hospital
Global Point Prevalence Survey of Antimicrobial Consumption and Resistance in hospitals worldwide Hospital ID: 831 Habib Bourguiba Hospital Tertiary hospital Tunisia Point Prevalence Survey Habib 2017
More informationProceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium
www.ivis.org Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium May 17-20, 2015 Fort Collins, CO, USA Reprinted in the IVIS website with the permission
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More informationESCHERICHIA COLI RESISTANCE AND GUT MICROBIOTA PROFILE IN PIGS RAISED WITH DIFFERENT ANTIMICROBIAL ADMINISTRATION IN FEED
ESCHERICHIA COLI RESISTANCE AND GUT MICROBIOTA PROFILE IN PIGS RAISED WITH DIFFERENT ANTIMICROBIAL ADMINISTRATION IN FEED Caroline Pissetti 1, Jalusa Deon Kich 2, Heather K. Allen 3, Claudia Navarrete
More informationPreventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal
Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal 07.03.01 2009 Methicillin Resistant Staphlococcus aureus (MRSA) About 3-8% of the population at large is a carrier
More informationINTERNATIONAL SYMPOSIUM ON ANTIMICROBIAL RESISTANCE
INTERNATIONAL SYMPOSIUM ON ANTIMICROBIAL RESISTANCE Combating Bacterial Resistance: many sizes to fit all Santiago de Cali, March 7TH, 8TH, 9TH 2018 Intercontinental Hotel Academic Program "Gato de Tejada"
More informationTrends of 9,416 multidrug-resistant Gram-negative bacteria
ORIGINAL ARTICLE Oliveira VDC et al. Trends of 9,416 multidrug-resistant Gram-negative bacteria Viviane Decicera Colombo Oliveira 1 *, Fernando Góngora Rubio 2, Margarete Teresa Gottardo Almeida 2, Mara
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationStudy of drug resistance pattern of principal ESBL producing urinary isolates in an urban hospital setting in Eastern India
Research article Study of drug resistance pattern of principal ESBL producing urinary isolates in an urban hospital setting in Eastern India Mitali Chatterjee, 1 M. Banerjee, 1 S. Guha, 2 A.Lahiri, 3 K.Karak
More informationWhat s next in the antibiotic pipeline?
What s next in the antibiotic pipeline? Jennifer Tieu, Pharm.D., BCPS Clinical Pearls OSHP Spring Meeting Mercy Hospital April 13, 2018 Objective 2 Describe the drug class and mechanism of action of antibiotics
More informationAntimicrobial Resistance and Prescribing
Antimicrobial Resistance and Prescribing John Ferguson, Microbiology & Infectious Diseases, John Hunter Hospital, University of Newcastle, NSW, Australia M Med Part 1 updates UPNG 2017 Tw @mdjkf http://idmic.net
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and
More informationDrive More Efficient Clinical Action by Streamlining the Interpretation of Test Results
White Paper: Templated Report Comments Drive More Efficient Clinical Action by Streamlining the Interpretation of Test Results Background The availability of rapid, multiplexed technologies for the comprehensive
More informationTestimony of the Natural Resources Defense Council on Senate Bill 785
Testimony of the Natural Resources Defense Council on Senate Bill 785 Senate Committee on Healthcare March 16, 2017 Position: Support with -1 amendments I thank you for the opportunity to address the senate
More informationDecrease of vancomycin resistance in Enterococcus faecium from bloodstream infections in
AAC Accepted Manuscript Posted Online 30 March 2015 Antimicrob. Agents Chemother. doi:10.1128/aac.00513-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 Decrease of vancomycin
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationPresenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update
Emergence of invasive Carbapenem Resistant Enterobacteriaceae CRE infection at RCWMCH Ombeva Oliver Malande, Annerie du Plessis, Colleen Bamford, Brian Eley Presenter: Ombeva Malande Red Cross Children's
More informationNew Drugs for Bad Bugs- Statewide Antibiogram
New Drugs for Bad Bugs- Statewide Antibiogram Felicia Matthews, Pharm.D., BCPS Senior Consultant, Pharmacy Specialty BE MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda
More informationANTIBIOTIC STEWARDSHIP
ANTIBIOTIC STEWARDSHIP S.A. Dehghan Manshadi M.D. Assistant Professor of Infectious Diseases and Tropical Medicine Tehran University of Medical Sciences Issues associated with use of antibiotics were recognized
More informationResistance trends of Acinetobacter
International Journal of Infectious Diseases (2004) 8, 284 291 Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains:
More informationService Delivery and Safety Department World Health Organization, Headquarters
Service Delivery and Safety Department World Health Organization, Headquarters WHO global (laboratory-based) survey on multidrug-resistant organisms (MDROs) in health care PROJECT SUMMARY Given the important
More informationOccurrence and the susceptibility to antimicrobial agents in Pseudomonas aeruginosa and Acinetobacter sp. at a tertiary hospital in southern Brazil
Revista da Sociedade Brasileira de Medicina Tropical 44(2):168-172, mar-abr, 2011 DOI: 10.1590/S0037-86822011005000015 Article/Artigo Occurrence and the susceptibility to antimicrobial agents in Pseudomonas
More informationManagement of Hospital-acquired Pneumonia
Management of Hospital-acquired Pneumonia Adel Alothman, MB, FRCPC, FACP Asst. Professor, COM, KSAU-HS Head, Infectious Diseases, Department of Medicine King Abdulaziz Medical City Riyadh Saudi Arabia
More information5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)
Multidrug Resistant Organisms (MDROs) Kasturi Shrestha, M.D. 05/11/2018 Objectives Define a multi-drug resistant organism (MDRO) Identify most challenging MDROs in healthcare Identify reasons for health
More informationOver the past several decades, the frequency of. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years. Ronald N.
Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years Ronald N. Jones, MD Multiple surveillance studies have demonstrated that resistance among prevalent pathogens is increasing
More informationAntimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana
Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana Beverly Egyir, PhD Noguchi Memorial Institute for Medical Research Bacteriology Department, University of Ghana Background
More informationINCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS
INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS 1 Research Associate, Drug Utilisation Research Unit, Nelson Mandela University 2 Human Sciences Research Council,
More information11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:
Hospital-acquired Infections Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More informationSusceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System
Polish Journal of Microbiology 2005, Vol. 54, No 4, 311 316 Susceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System EL BIETA STEFANIUK*, AGNIESZKA MRÓWKA
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL
ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance
More informationRegional Workshop on AMR in South East Asia Penang (Malaysia): March 2018
Regional Workshop on AMR in South East Asia Penang (Malaysia): 26-28 March 2018 Prof : Htay Htay Tin drhtayhtaytin@gmail.com DDG ( Laboratory) National Focal Point for AMR Ministry of Health and Sports
More informationAntibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011
Antibiotic Resistance Antibiotic Resistance: A Growing Concern Judy Ptak RN MSN Infection Prevention Practitioner Dartmouth-Hitchcock Medical Center Lebanon, NH Occurs when a microorganism fails to respond
More informationPrevalenceofAntimicrobialResistanceamongGramNegativeIsolatesinanAdultIntensiveCareUnitataTertiaryCareCenterinSaudiArabia
: K Interdisciplinary Volume 17 Issue 4 Version 1.0 Year 2017 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618 & Print ISSN:
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationAntimicrobial stewardship: Quick, don t just do something! Stand there!
Antimicrobial stewardship: Quick, don t just do something! Stand there! Stanley I. Martin, MD, FACP, FIDSA Director, Division of Infectious Diseases Director, Antimicrobial Stewardship Program Geisinger
More informationMetallo Beta Lactamase Producing Pseudomonas aeruginosa in a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 11 (2016) pp. 269-274 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.511.029
More informationJournal of Hospital Infection
Journal of Hospital Infection 75 () 23 27 Available online at www.sciencedirect.com Journal of Hospital Infection journal homepage: www.elsevierhealth.com/journals/jhin Impact of hospital-wide infection
More informationNorthwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America
More informationOPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS
HTIDE CONFERENCE 2018 OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS FEDERICO PEA INSTITUTE OF CLINICAL PHARMACOLOGY DEPARTMENT OF MEDICINE, UNIVERSITY OF UDINE, ITALY SANTA
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.
More information